Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
The vice-president of Germany’s central bank has a warning for lenders as insolvencies rise
Germany’s banks must increase provisions for loan losses, as corporate insolvencies and credit risks mount, according to Bundesbank Vice-President Claudia Buch. Post Views: 89
Euro holds steady against dollar ahead of Eurozone PMI data
Post Content Post Views: 73
PureHealth acquires PureCS to bolster tech before IPO
Post Content Post Views: 77
It sounds fishy, but SBF really IS trading mackerel in prison: Report
Post Content Post Views: 81
65% plunge in Web3 Games in ’23 but ‘real hits’ coming, $26M NFL Rivals NFT: Web3 Gamer
Post Content Post Views: 72
Earnings call: Reading International Q3 2023 results reflect strong recovery, asset monetization in focus
Post Content Post Views: 82